Chromosomal Microarray Testing for Children With Unexplained Neurodevelopmental Disorders.
作者信息
Martin Christa Lese, Ledbetter David H
机构信息
Geisinger Health System, Danville, Pennsylvania.
出版信息
JAMA. 2017 Jun 27;317(24):2545-2546. doi: 10.1001/jama.2017.7272.
Abstract
摘要
相似文献
1
Chromosomal Microarray Testing for Children With Unexplained Neurodevelopmental Disorders.
JAMA. 2017 Jun 27;317(24):2545-2546. doi: 10.1001/jama.2017.7272.
2
Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
Eur J Paediatr Neurol. 2013 Nov;17(6):589-99. doi: 10.1016/j.ejpn.2013.04.010. Epub 2013 May 24.
3
Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Genet Med. 2018 Oct;20(10):1105-1113. doi: 10.1038/s41436-018-0040-6. Epub 2018 Jun 18.
4
Application of chromosomal microarrays in the evaluation of intellectual disability/global developmental delay patients - A study from a tertiary care genetic centre in India.
Gene. 2016 Sep 15;590(1):109-19. doi: 10.1016/j.gene.2016.06.020. Epub 2016 Jun 9.
5
Cost Effectiveness of Karyotyping, Chromosomal Microarray Analysis, and Targeted Next-Generation Sequencing of Patients with Unexplained Global Developmental Delay or Intellectual Disability.
Mol Diagn Ther. 2018 Feb;22(1):129-138. doi: 10.1007/s40291-017-0309-5.
6
Clinical Performance of an Ultrahigh Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
Biomed Res Int. 2016;2016:3284534. doi: 10.1155/2016/3284534. Epub 2016 Nov 16.
7
The utility of chromosomal microarray analysis in developmental and behavioral pediatrics.
Child Dev. 2013 Jan-Feb;84(1):121-32. doi: 10.1111/cdev.12050. Epub 2013 Jan 11.
8
Chromosomal microarray analysis in clinical evaluation of neurodevelopmental disorders-reporting a novel deletion of SETDB1 and illustration of counseling challenge.
Pediatr Res. 2016 Sep;80(3):371-81. doi: 10.1038/pr.2016.101. Epub 2016 Apr 27.
9
Phenotypic Analysis of Korean Patients with Abnormal Chromosomal Microarray in Patients with Unexplained Developmental Delay/Intellectual Disability.
Yonsei Med J. 2018 May;59(3):431-437. doi: 10.3349/ymj.2018.59.3.431.
10
Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
Ann Lab Med. 2019 May;39(3):299-310. doi: 10.3343/alm.2019.39.3.299.
引用本文的文献
1
Advances in chromosomal microarray analysis: Transforming neurology and neurosurgery.
Brain Spine. 2025 Jan 25;5:104197. doi: 10.1016/j.bas.2025.104197. eCollection 2025.
2
Genetic Testing for Global Developmental Delay in Early Childhood.
JAMA Netw Open. 2024 Jun 3;7(6):e2415084. doi: 10.1001/jamanetworkopen.2024.15084.
3
Rare genetic disorders and the heightened importance of baseline motor examinations in children and adolescents experiencing a first episode of psychosis.
Eur Child Adolesc Psychiatry. 2025 Feb;34(2):811-813. doi: 10.1007/s00787-024-02449-z. Epub 2024 Apr 26.
4
Genetic spectrums and clinical profiles of critically ill neonates with congenital auricular deformity in the China Neonatal Genomes Project.
Hum Genet. 2023 Dec;142(12):1737-1745. doi: 10.1007/s00439-023-02612-7. Epub 2023 Nov 8.
5
A Rare Case of Mosaic 3pter and 5pter Deletion-Duplication with Autism Spectrum Disorder and Dyskinesia.
Case Rep Genet. 2023 Oct 16;2023:7974886. doi: 10.1155/2023/7974886. eCollection 2023.
6
Identification of copy number variants with genome sequencing: Clinical experiences from the NYCKidSeq program.
Clin Genet. 2023 Aug;104(2):210-225. doi: 10.1111/cge.14365. Epub 2023 Jun 19.
7
Multisite Assessment of Optical Genome Mapping for Analysis of Structural Variants in Constitutional Postnatal Cases.
J Mol Diagn. 2023 Mar;25(3):175-188. doi: 10.1016/j.jmoldx.2022.12.005.
8
Genomic Aberrations Associated with the Pathophysiological Mechanisms of Neurodevelopmental Disorders.
Cells. 2021 Sep 4;10(9):2317. doi: 10.3390/cells10092317.
9
Diagnostic Utility of Genome-Wide DNA Methylation Analysis in Mendelian Neurodevelopmental Disorders.
Int J Mol Sci. 2020 Dec 6;21(23):9303. doi: 10.3390/ijms21239303.
10
Short stature and growth hormone deficiency in a subset of patients with Potocki-Lupski syndrome: Expanding the phenotype of PTLS.
Am J Med Genet A. 2020 Sep;182(9):2077-2084. doi: 10.1002/ajmg.a.61741. Epub 2020 Jul 13.
本文引用的文献
1
Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder.
JAMA. 2015 Sep 1;314(9):895-903. doi: 10.1001/jama.2015.10078.
2
Practical guidelines for managing adults with 22q11.2 deletion syndrome.
Genet Med. 2015 Aug;17(8):599-609. doi: 10.1038/gim.2014.175. Epub 2015 Jan 8.
3
Comprehensive evaluation of the child with intellectual disability or global developmental delays.
Pediatrics. 2014 Sep;134(3):e903-18. doi: 10.1542/peds.2014-1839.
4
Microarray as a first genetic test in global developmental delay: a cost-effectiveness analysis.
Dev Med Child Neurol. 2011 Nov;53(11):994-9. doi: 10.1111/j.1469-8749.2011.04080.x. Epub 2011 Aug 16.
5
American College of Medical Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities.
Genet Med. 2011 Jul;13(7):676-9. doi: 10.1097/GIM.0b013e31822272ac.
6
Practical guidelines for managing patients with 22q11.2 deletion syndrome.
J Pediatr. 2011 Aug;159(2):332-9.e1. doi: 10.1016/j.jpeds.2011.02.039. Epub 2011 May 12.
7
Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities.
Genet Med. 2010 Nov;12(11):742-5. doi: 10.1097/GIM.0b013e3181f8baad.
8
Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.
Am J Hum Genet. 2010 May 14;86(5):749-64. doi: 10.1016/j.ajhg.2010.04.006.
Zotero 插件